92 related articles for article (PubMed ID: 17568791)
21. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
22. [Model program for screening oral cancers in the Roma population].
Csépe P; Bánóczy J; Dombi C; Forrai J; Gyenes M; Döbrossy L
Magy Onkol; 2007; 51(2):95-101. PubMed ID: 17660865
[TBL] [Abstract][Full Text] [Related]
23. Molecular markers and targets for colorectal cancer prevention.
Janakiram NB; Rao CV
Acta Pharmacol Sin; 2008 Jan; 29(1):1-20. PubMed ID: 18158862
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus vaccines and anal carcinoma.
Franceschi S; De Vuyst H
Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
[TBL] [Abstract][Full Text] [Related]
25. Lycopene in the prevention of prostate cancer.
Dahan K; Fennal M; Kumar NB
J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
[TBL] [Abstract][Full Text] [Related]
26. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
[TBL] [Abstract][Full Text] [Related]
27. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.
Piccini JP; Whellan DJ; Berridge BR; Finkle JK; Pettit SD; Stockbridge N; Valentin JP; Vargas HM; Krucoff MW;
Am Heart J; 2009 Sep; 158(3):317-26. PubMed ID: 19699852
[TBL] [Abstract][Full Text] [Related]
28. Soy isoflavone genistein in prevention and treatment of prostate cancer.
Perabo FG; Von Löw EC; Ellinger J; von Rücker A; Müller SC; Bastian PJ
Prostate Cancer Prostatic Dis; 2008; 11(1):6-12. PubMed ID: 17923857
[TBL] [Abstract][Full Text] [Related]
29. [The distribution of the pre-cancerous condition and pathological changes of esophageal cancer of the community residents in high-incidence area].
Zhao DL; Li HQ; Ji P; Zhou RX; Lei FH; Diao YT; Li H; Yang YF; Zhou YZ; Wang Y; Yin C; Fang XQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 May; 42(5):345-8. PubMed ID: 18844086
[TBL] [Abstract][Full Text] [Related]
30. [Defining an ethics for preventive trials].
Chippaux JP
Bull Soc Pathol Exot; 2008 Apr; 101(2):85-9. PubMed ID: 18543698
[TBL] [Abstract][Full Text] [Related]
31. Lycopene in cancer prevention and treatment.
Seren S; Lieberman R; Bayraktar UD; Heath E; Sahin K; Andic F; Kucuk O
Am J Ther; 2008; 15(1):66-81. PubMed ID: 18223356
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
[TBL] [Abstract][Full Text] [Related]
33. Silibinin modulates biotransforming microbial enzymes and prevents 1,2-dimethylhydrazine-induced preneoplastic changes in experimental colon cancer.
Sangeetha N; Felix AJ; Nalini N
Eur J Cancer Prev; 2009 Sep; 18(5):385-94. PubMed ID: 19654488
[TBL] [Abstract][Full Text] [Related]
34. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions.
Clapper ML; Cooper HS; Chang WC
Acta Pharmacol Sin; 2007 Sep; 28(9):1450-9. PubMed ID: 17723178
[TBL] [Abstract][Full Text] [Related]
35. Interferons in precancer and cancer prevention: where are we?
Tanneberger S; Hrelia P
J Interferon Cytokine Res; 1996 May; 16(5):339-46. PubMed ID: 8727073
[TBL] [Abstract][Full Text] [Related]
36. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
O'Shaughnessy JA; Kelloff GJ; Gordon GB; Dannenberg AJ; Hong WK; Fabian CJ; Sigman CC; Bertagnolli MM; Stratton SP; Lam S; Nelson WG; Meyskens FL; Alberts DS; Follen M; Rustgi AK; Papadimitrakopoulou V; Scardino PT; Gazdar AF; Wattenberg LW; Sporn MB; Sakr WA; Lippman SM; Von Hoff DD
Clin Cancer Res; 2002 Feb; 8(2):314-46. PubMed ID: 11839647
[TBL] [Abstract][Full Text] [Related]
37. Perspectives on chemoprevention agent selection and short-term clinical prevention trials.
Kelloff GJ; Hawk ET; Crowell JA; Boone CW; Steele VE; Lubet RA; Sigman CC
Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():79-85. PubMed ID: 9061299
[No Abstract] [Full Text] [Related]
38. Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptations.
Furth PA
Ann N Y Acad Sci; 2012 Oct; 1271(1):1-9. PubMed ID: 23050958
[TBL] [Abstract][Full Text] [Related]
39. Workshop on imaging science development for cancer prevention and preemption.
Kelloff GJ; Sullivan DC; Baker H; Clarke LP; Nordstrom R; Tatum JL; Dorfman GS; Jacobs P; Berg CD; Pomper MG; Birrer MJ; Tempero M; Higley HR; Petty BG; Sigman CC; Maley C; Sharma P; Wax A; Ginsberg GG; Dannenberg AJ; Hawk ET; Messing EM; Grossman HB; Harisinghani M; Bigio IJ; Griebel D; Henson DE; Fabian CJ; Ferrara K; Fantini S; Schnall MD; Zujewski JA; Hayes W; Klein EA; DeMarzo A; Ocak I; Ketterling JA; Tempany C; Shtern F; Parnes HL; Gomez J; Srivastava S; Szabo E; Lam S; Seibel EJ; Massion P; McLennan G; Cleary K; Suh R; Burt RW; Pfeiffer RM; Hoffman JM; Roy HK; Wang T; Limburg PJ; El-Deiry WS; Papadimitrakopoulou V; Hittelman WN; MacAulay C; Veltri RW; Solomon D; Jeronimo J; Richards-Kortum R; Johnson KA; Viner JL; Stratton SP; Rajadhyaksha M; Dhawan A;
Cancer Biomark; 2007; 3(1):1-33. PubMed ID: 17655039
[TBL] [Abstract][Full Text] [Related]
40. Precancer biology: importance and possible prevention. Introduction.
Pontén J
Cancer Surv; 1998; 32():1-3. PubMed ID: 10489620
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
